Fluidic Analytics showcases protein analysis expertise across Europe

Fluidic Analytics Ltd, a pioneer in protein analysis and the company behind in-solution diffusional sizing, will attend a number of events this Autumn to showcase its revolutionary technology for studying protein interactions. At each event across Europe, the team will present data from its pre-release instrument – the Fluidity One-W – which allows researchers to assess on-target protein interactions in solution and even in crude biological backgrounds.

The Fluidity One-W opens up the possibilities for detailed protein analysis in near-native states and natural environments, providing researchers with accurate and complete protein interaction data. Its ability to generate absolute size measurements through the proprietary method of microfluidic diffusional sizing (MDS) ensures confidence in the data collected and allows users to control for off-target binding and false positive measurements. Detailed protein interaction information including binding kinetics, KD calculations and stoichiometries can be generated, allowing researchers to gain the best insight into a protein’s behavior in the cell. The Fluidity One-W is also remarkably easy-to-use, operating on a pipette, plug and play basis with minimal sample preparation to reduce time and costs and allow analysis at the earliest possible stage.

At a number of the European events, Fluidic Analytics will be presenting data and talking about the new possibilities for protein analysis with MDS during short talks:

  • Dutch BioPhysics (Veldhoven, Netherlands, 7th-8th October)
  • Tools for the structural biology of membrane proteins (Hamburg, Germany, 7th-9th October)
  • BSI-2019 (Toulouse, France, 7th-11th October)
    • Including a 15-minute presentation, Tuesday 8th @ 09.15
  • GPCR International Meeting (Montpellier, France, 9th-11th October)
    • Including a 5-minute presentation, Friday 11th @ 10.55
  • PSDI 2019 (Cambridge, UK, 3rd-5th November)
  • Drug Discovery 2019 (Liverpool, UK, 5th-6th November)
  • Bioscience 2019 (Stockholm, Sweden, 7th November)
    • Including a 20-minute presentation – timing TBC

“We’re really looking forward to presenting new data and showcasing our newest instrument, the Fluidity One-W, ahead of its release later in the year. It’s a really exciting platform, that has a whole range of applications from neurobiology and structural biology to drug discovery. With its unique capabilities in-solution, the Fluidity One-W is the best option for analyzing difficult-to-study proteins like amyloid fibrils and large complexes, and so having one in the laboratory can really expand the types of proteins and systems that can be investigated. With our new approach to protein analysis, researchers can be sure of accurate, quality data for often previously inaccessible targets”

Dr Sean Devenish, Fluidic Analytics

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Fluidic Analytics. (2023, March 29). Fluidic Analytics showcases protein analysis expertise across Europe. News-Medical. Retrieved on May 09, 2024 from https://www.news-medical.net/news/20230208/Fluidic-Analytics-showcases-protein-analysis-expertise-across-Europe.aspx.

  • MLA

    Fluidic Analytics. "Fluidic Analytics showcases protein analysis expertise across Europe". News-Medical. 09 May 2024. <https://www.news-medical.net/news/20230208/Fluidic-Analytics-showcases-protein-analysis-expertise-across-Europe.aspx>.

  • Chicago

    Fluidic Analytics. "Fluidic Analytics showcases protein analysis expertise across Europe". News-Medical. https://www.news-medical.net/news/20230208/Fluidic-Analytics-showcases-protein-analysis-expertise-across-Europe.aspx. (accessed May 09, 2024).

  • Harvard

    Fluidic Analytics. 2023. Fluidic Analytics showcases protein analysis expertise across Europe. News-Medical, viewed 09 May 2024, https://www.news-medical.net/news/20230208/Fluidic-Analytics-showcases-protein-analysis-expertise-across-Europe.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.